Xinlong Health Proposes to Provide 260 Million Yuan Financing Guarantee for Subsidiary

Rayda Finance Text | Yang Yang Edited | Li Yihui

On March 18, Xinlong Health (Stock Code: 002105) announced that the company held the second meeting of the eighth board of directors on March 17, 2026, during which it approved a proposal for its wholly-owned subsidiary, Tianjin Xinlong Industrial Co., Ltd., to apply for a total financing limit of RMB 260 million from nine banks in 2026, with the company providing a 100% joint liability guarantee. As of December 31, 2025, Tianjin Xinlong’s asset-liability ratio was 68.28%.

This guarantee does not require submission to the shareholders’ meeting and does not involve related-party transactions. The company and its subsidiaries have no overdue guarantees or guarantees involved in litigation.

According to Tianyancha, Xinlong Health was established on October 27, 1991, with a registered capital of RMB 366.24195 million. The legal representative is Liao Xuejin, and the registered address is No. 1 Biteng Road, Bitou Community, Songgang Street, Bao’an District, Shenzhen. Its main business includes research and development, production, and sales of bicycle parts (such as handlebars, seat posts, seat tubes, front suspension forks, disc brakes), sports equipment, rehabilitation assistive devices, aluminum extrusion products, and pipe processing.

Currently, the company’s chairman is Liao Xuejin, the secretary of the board is Chen Liqiu, with 2,477 employees, and the actual controller is Liao Xuejin.

The company has 11 associated companies, including Xinlong Industrial (Hong Kong) Limited, Xinlong Health Industry (Taicang) Co., Ltd., Tianjin Xinlong Industrial Co., Ltd., Shenzhen Laike Technology Co., Ltd., Tianjin Reem Industrial Co., Ltd., and others.

In terms of performance, the company’s operating income for 2022, 2023, and 2024 was RMB 1.825 billion, RMB 964 million, and RMB 1.191 billion, respectively, with year-on-year changes of -30.72%, -47.18%, and +23.58%. Net profit attributable to the parent was RMB 189 million, RMB 21.7027 million, and a loss of RMB 18.9339 million, with year-on-year changes of -30.58%, -88.53%, and -187.24%. During the same period, the company’s asset-liability ratios were 44.04%, 41.98%, and 44.96%.

Regarding risks, Tianyancha data shows the company has 611 internal Tianyan risks, 15 surrounding risks, 132 historical risks, and 91 warning alert risks.